Helsinn Announces Completion of its new Stability Centre at its Irish Drug Product Manufacturing Facility

23-Oct-2009 - Ireland

Helsinn announced the completion of its state of the art Stability Centre at its Helsinn Birex Pharmaceuticals facility in Dublin, Ireland.

The new facility which has a total storage capacity of 24 cu meters, contains a range of stability chambers which will operate at ICH conditions of 25 degrees C/60% RH, 30 degrees C/65% RH, and 40 degrees C/75% RH. It also has a refrigerated chamber to store samples at 5degreesC and a freezer at minus 20 degrees C.

The centre has the capacity to meet foreseeable stability requirements of the Helsinn Group for commercial and development products currently in the Helsinn pipeline. It is also available as a service for third party clients.

"The completion of this new stability center at Helsinn Birex Pharmaceuticals provides an important addition to Helsinn's capability to monitor the quality of its product portfolio as part of its commitment to excellent service to its customers worldwide," saysPadraig Somers, General Manager.

Other news from the department manufacturing

Most read news

More news from our other portals

Fighting cancer: latest developments and advances